PetMed Express financials
$1.40−0.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 | FY21 Mar 31 | FY20 Mar 31 | FY19 Mar 31 | FY18 Mar 31 | FY17 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $274.1M | $247.6M | $272.3M | $303.6M | $284.1M | $283.4M | $273.8M | $249.2M |
| Gross profit | $52.3M | $69.1M | $84.8M | $76.5M | $76.9M | $84.3M | $81.2M | $95.3M | $97.8M | $79.3M |
| Gross margin | 29.2% | 30.5% | 30.9% | 30.9% | 28.3% | 27.8% | 28.6% | 33.6% | 35.7% | 31.8% |
| Operating income | -$58.7M | -$1.5M | -$8.2M | $6.1M | $24.3M | $30.5M | $31.0M | $46.2M | $52.1M | $37.5M |
| Net income | -$57.3M | -$6.3M | -$7.5M | $5.1M | $18.7M | $23.9M | $25.9M | $37.7M | $37.3M | $23.8M |
| Net margin | −32.0% | −2.8% | −2.7% | 2.1% | 6.9% | 7.9% | 9.1% | 13.3% | 13.6% | 9.6% |
| Diluted EPS | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 |
| EBITDA | -$19.9M | $6.7M | -$1.1M | $9.6M | $27.0M | $33.0M | $33.2M | $48.4M | $54.3M | $38.9M |
| Operating cash flow | -$28.4M | $4.7M | $4.3M | $27.8M | $18.5M | $40.1M | $38.8M | $45.1M | $37.4M | $47.2M |
| Free cash flow | -$33.0M | -$395.0K | -$194.0K | $22.5M | $16.7M | $37.6M | $36.5M | $44.5M | $36.7M | $36.6M |
| Diluted shares | 20.9M | 20.6M | 20.4M | 20.3M | 20.4M | 20.1M | 20.1M | 20.5M | 20.4M | 20.4M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $21.4M | $54.7M | $55.3M | $104.1M | $111.1M | $118.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $81.2M | $148.7M | $169.9M | $167.5M | $179.7M | $187.5M |
| Total liabilities | $52.3M | $63.6M | $73.2M | $57.5M | $56.2M | $46.2M |
| Shareholders' equity | $28.9M | $85.1M | $96.7M | $110.0M | $123.5M | $141.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology